Muscle wasting in cardiac cachexia

被引:80
作者
Strassburg, S
Springer, J
Anker, SD
机构
[1] Charite, Dept Cardiol, Div Appl Cachexia Res, D-13353 Berlin, Germany
[2] Univ London Imperial Coll Sci & Technol, NHLI, Dept Clin Cardiol, London, England
关键词
muscle; cachexia; wasting; chronic heart failure;
D O I
10.1016/j.biocel.2005.03.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cardiac cachexia is a serious complication of chronic heart failure which is characterized by complex changes that overall lead to a catabolic/anabolic imbalance resulting in body wasting and a poor prognosis. The wasting process affects all body components, but particularly the skeletal musculature, causing extreme fatigue and weakness, especially in cachectic heart failure patients. Available evidence suggests that several pathophysiologic pathways play a role in the muscle wasting process. Metabolic, neurohormonal, and immune abnormalities lead to an altered regulation of proliferation, differentiation, apoptosis, and metabolism in skeletal muscle, finally resulting in deterioration of the underlying cause with symptomatic exercise intolerance. Possible treatment strategies against muscle wasting and cachexia in chronic heart failure are also described here. As there is no validated therapy for cardiac cachexia yet, further research is necessary to find more therapeutic options for the wasting process. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1938 / 1947
页数:10
相关论文
共 87 条
[1]   PHYSICAL-TRAINING IMPROVES SKELETAL-MUSCLE METABOLISM IN PATIENTS WITH CHRONIC HEART-FAILURE [J].
ADAMOPOULOS, S ;
COATS, AJS ;
BRUNOTTE, F ;
ARNOLDA, L ;
MEYER, T ;
THOMPSON, CH ;
DUNN, JF ;
STRATTON, J ;
KEMP, GJ ;
RADDA, GK ;
RAJAGOPALAN, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (05) :1101-1106
[2]   Induction of iNOS expression in skeletal muscle by IL-1β and NFκB activation:: an in vitro and in vivo study [J].
Adams, V ;
Nehrhoff, B ;
Späte, U ;
Linke, A ;
Schulze, PC ;
Baur, A ;
Gielen, S ;
Hambrecht, R ;
Schuler, G .
CARDIOVASCULAR RESEARCH, 2002, 54 (01) :95-104
[3]   Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: A potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation [J].
Adi, S ;
Bin-Abbas, B ;
Wu, NY ;
Rosenthal, SM .
ENDOCRINOLOGY, 2002, 143 (02) :511-516
[4]   Inflammatory mediators in chronic heart failure: An overview [J].
Anker, SD ;
von Haehling, S .
HEART, 2004, 90 (04) :464-470
[5]  
Anker SD, 1997, EUR HEART J, V18, P259
[6]   Cardiac cachexia [J].
Anker, SD ;
Steinborn, W ;
Strassburg, S .
ANNALS OF MEDICINE, 2004, 36 (07) :518-529
[7]   Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure [J].
Anker, SD ;
Ponikowski, PP ;
Clark, AL ;
Leyva, F ;
Rauchhaus, M ;
Kemp, M ;
Teixeira, MM ;
Hellewell, PG ;
Hooper, J ;
Poole-Wilson, PA ;
Coats, AJS .
EUROPEAN HEART JOURNAL, 1999, 20 (09) :683-693
[8]   Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study [J].
Anker, SD ;
Negassa, A ;
Coats, AJS ;
Afzal, R ;
Poole-Wilson, PA ;
Cohn, JN ;
Yusuf, S .
LANCET, 2003, 361 (9363) :1077-1083
[9]   Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging [J].
Anker, SD ;
Doehner, W ;
Rauchhaus, M ;
Sharma, R ;
Francis, D ;
Knosalla, C ;
Davos, CH ;
Cicoira, M ;
Shamim, W ;
Kemp, M ;
Segal, R ;
Osterziel, KJ ;
Leyva, F ;
Hetzer, R ;
Ponikowski, P ;
Coats, AJS .
CIRCULATION, 2003, 107 (15) :1991-1997
[10]   The syndrome of cardiac cachexia [J].
Anker, SD ;
Sharma, R .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 85 (01) :51-66